Itraconazole Oral Solution for Infantile Complicated Hemangioma with Double Lesions on the Skin and One Inside the Liver
Xian He,Xin Ran,Dan Liang,Hongxia Fan,Yuping Ran
DOI: https://doi.org/10.2147/ccid.s462665
2024-05-24
Clinical Cosmetic and Investigational Dermatology
Abstract:Xian He, 1, 2 Xin Ran, 1 Dan Liang, 2 Hongxia Fan, 3 Yuping Ran 1 1 Department of Dermatovenereology, West China Hospital, Sichuan University, Chengdu, People's Republic of China; 2 Department of Allergy, Chengdu First People's Hospital, Chengdu, People's Republic of China; 3 Department of Ultrasonic, West China Hospital, Sichuan University, Chengdu, People's Republic of China Correspondence: Yuping Ran, Tel +8618980601697, Email An infantile hemangioma is a congenital benign tumor formed by the proliferation of vascular cells during the embryonic stage. It is more common in the skin but can also occur in the mucous membranes, liver, brain and muscle. Hepatic hemangioma appears to be a benign tumor; however, it may lead to poor outcomes because of severe complications, such as high-output cardiac failure. The main treatment of hepatic hemangioma in infants is oral drugs, such as propranolol and glucocorticoids, but the clinical response is not always satisfactory. We describe a rare case of a 2-month-old boy who presented with infantile cutaneous and hepatic hemangiomas. By using dermoscopy and observations of the abdominal color Doppler ultrasound, after 9 months of oral treatment with itraconazole solution, the infantile cutaneous hemangioma complicated with hepatic hemangioma was eventually cured. There was no liver or kidney function damage during the whole treatment period. Itraconazole oral solution for the treatment of infantile cutaneous hemangioma complicated with hepatic hemangioma showed good efficacy, compliance, and safety in this case. Keywords: infantile hemangioma, cutaneous, hepatic, itraconazole oral solution, dermoscopy, color ultrasonic Infantile hemangioma (IH) is a congenital benign tumor formed by the proliferation of vascular cells during embryonic stages, affecting 1% to 2.6% of newborns and up to 10% of children by the first one year of age. 1 It is more common in the skin but can occur in the mucous membranes, liver, brain, and muscle. 1 Infantile hepatic hemangioma (IHH) is a benign tumor that originates from endothelial cells and is usually slowly progressive during childhood. Although most infants are asymptomatic and often overlooked by the parents and doctors, 15% may develop high-output cardiac failure, resulting in considerable mortality. 2–4 Current treatment methods for hepatic hemangioma include oral propranolol, systemic glucocorticosteroids, interferon, vincristine, cyclophosphamide, embolization, hepatic artery ligation, hepatectomy and liver transplantation. 5–10 However, many treatments have low success rates and a high risk of side effects. Kassarjian et al 11 reported that pharmacologic therapy fails in about one-third of patients, with an associated mortality rate of 11%. Oral propranolol is the first-line treatment for cutaneous hemangioma with hepatic complications, occasionally, its potential side effects, including drowsiness, bradycardia, low blood pressure, and hypoglycemia, are clinical concerns that needs attention. 12 Itraconazole (ICZ), a key member of the triazole antifungal family, is widely used in clinical antifungal drugs and has recently been found to possess antiangiogenic and inhibition of mTOR pathway and hedgehog activity. Our team has previously reported cases in which ICZ was used in infants with hemangioma. 13,14 Herein, we report a case of infantile cutaneous hemangioma complicated with hepatic hemangioma treated by oral ICZ solution. Dermoscopy and color ultrasound images play a vital role in the diagnosis and in the therapeutic efficacy monitoring. A full-term fraternal twin male infant presented at 1 week of age with irregular erythema on the left anterior chest and left upper abdomen. The lesions gradually bulged, enlarged, brightened, and developed progressively into elevated erythema plaques (Figure 1). The patient was treated with topical 0.5% timolol maleate eye drops for one month in other hospital before the current treatment, but it did not stop the IH from growing. Physical examination revealed two irregular erythematous plaques of approximately 3.0 × 1.8 cm in size on the left anterior chest and 2.6 × 1.4 cm in size on the left upper abdomen (Figure 1). Dermoscopy revealed an intensive vascular network (Figure 2). The multiple lesions prompt us screening for liver hemangioma. 15 Indeed, abdominal ultrasound revealed an approximately 1.3 × 0.9 × 1.5 cm hemangiomatoid solid mass in the patient's right liver (Figure 3), and the hemogram showed an abundant blood flow signal in the mass (Figure 4), the diagnosis was consistent with Infantile hepatic hemangioma (IHH). After fully communicating with the mother and informing her of the benefits and risks of i -Abstract Truncated-
dermatology